Chemomab Therapeutics Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Chemomab Therapeutics Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Chemomab Therapeutics Ltd. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $341K, a 113% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $341K +$181K +113% Jun 30, 2024 6-K 2024-08-21
Q4 2023 $392K +$165K +72.7% Dec 31, 2023 6-K 2024-08-21
Q2 2023 $160K -$135K -45.8% Jun 30, 2023 6-K 2023-08-14
Q1 2023 $193K -$116K -37.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $227K -$118K -34.2% Dec 31, 2022 20-F 2024-03-28
Q3 2022 $261K -$98K -27.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $295K -$97K -24.7% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $309K -$88K -22.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $345K -$83K -19.4% Dec 31, 2021 20-F 2024-03-28
Q3 2021 $359K +$125K +53.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $392K +$117K +42.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $397K +$58K +17.1% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $428K -$771K -64.3% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $234K Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $275K Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $339K Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.2M -$610K -33.7% Dec 31, 2019 10-K 2021-03-09
Q4 2018 $1.81M Jan 1, 2019 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.